Company intelligence / Profile preview

Plasson

Ownership: Private
Development stage: Commercial

Overview

Plasoron Biotech operates a commercial portfolio focused on nephrology, orthopedics, gynecology, critical care, rheumatology and holistic wellness. Products include biotech medicines, high-end segment-specific drugs, antibiotics and hormones. All products are manufactured at WHO-GMP & ISO-certified facilities with robust quality control. Clinical trial results or investigational programs are not reported publicly.

Therapeutic areas: EndocrinologyOtherRheumatologyNephrologyWomen's Health
Modalities: Small moleculeBiologicHormoneAntibiotic
Industry: Biotech

Partnerships

Strategic production arrangements with globally benchmarked manufacturing facilities; specifics not disclosed.

Beyond the preview

Go deeper on Plasson.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasson.

Explore the full profile